The Week in Review #47
What A Week For Biotechnology
In this “Week in Review” there is no complicated scientific and clinical information, leaving the details to the articles that we usually post on the Prohost website.
Most of the Prohost picked firms’ Q3 financial results have beaten expectations. Three firms have reached the Prohost 2019 targets, and more firms have outperformed, with some rebounding from an unwarranted selloff. A small number of biotech firms looked paralyzed, causing investors’ skepticism about their technological effectiveness, their plans and strategies.
This content is for paid subscribers.